Genscript Biotech Corporation (HKG: 1548)

Genscript Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	399.3	1,446	1,024	1,181	629.06	252.4
Short-Term Investments	1,328	376.22	228.89	222.53	137.46	148.69
Trading Asset Securities	151.29	105.65	210.82	2.21	5.87	25.43
Cash & Short-Term Investments	1,879	1,928	1,464	1,406	772.38	426.52
Cash Growth	-12.27%	31.74%	4.13%	82.00%	81.09%	-24.46%
Accounts Receivable	130.81	218.83	104.28	142.44	141.75	73.07
Other Receivables	103.68	80.66	66.13	22.46	20.32	12.8
Receivables	234.53	299.53	170.44	166.58	164.49	87.87
Inventory	50.86	53.35	59.94	44.36	31.75	16.49
Prepaid Expenses	11.58	1.99	2.13	5.48	3.68	1.85
Restricted Cash	9.64	33.07	27.2	1.44	7.47	0.97
Other Current Assets	28.7	36.91	41.53	15.49	13.41	20.35
Total Current Assets	2,214	2,353	1,765	1,639	993.17	554.05
Property, Plant & Equipment	813.72	728.73	624.67	486.91	379.23	265.63
Long-Term Investments	96.73	85.41	16.03	18.47	13.99	7.28
Goodwill	1.35	1.36	2.55	14.15	14.12	15.25
Other Intangible Assets	16.08	18.65	23.81	26.42	26.02	25.48
Long-Term Accounts Receivable	0.23	0.29	0.4	-	-	-
Long-Term Deferred Tax Assets	15.13	16.51	15.05	5.09	3.7	5.7
Other Long-Term Assets	174.31	183.26	98.93	43.77	17.17	16.03
Total Assets	3,332	3,387	2,546	2,234	1,447	889.41
Accounts Payable	59.21	39.96	55.76	30.18	23.38	17.63
Accrued Expenses	188.69	164.77	210.03	156.11	114.4	89.15
Short-Term Debt	31.02	56.94	33.23	-	44.06	16.46
Current Portion of Long-Term Debt	-	0.07	0.45	0.52	0.58	0.55
Current Portion of Leases	14.46	8.87	11.1	7.51	2.59	1.77
Current Income Taxes Payable	15.58	18.13	16.15	15.72	3.53	2.85
Current Unearned Revenue	122.96	98.58	44.33	35.47	84.79	60.22
Other Current Liabilities	101.08	107.49	174.93	167.79	54.58	35.89
Total Current Liabilities	533	494.81	545.98	413.31	327.91	224.51
Long-Term Debt	846.15	712.72	567.23	381.86	1.26	1.75
Long-Term Leases	97.6	63.91	44.01	27.35	6.51	3.61
Long-Term Unearned Revenue	2.7	47.96	2.01	15.54	288.55	281.67
Long-Term Deferred Tax Liabilities	7.51	5.62	8.01	7.73	7.03	5.58
Other Long-Term Liabilities	20.71	17.93	16.48	0.4	0.55	-
Total Liabilities	1,508	1,343	1,184	846.18	631.82	517.11
Common Stock	2.13	2.12	2.11	2.1	1.95	1.88
Additional Paid-In Capital	1,975	1,939	1,473	1,274	1,067	368.78
Retained Earnings	-772.84	-597.73	-502.25	-275.4	-175.01	29.94
Treasury Stock	-8.31	-9.45	-11.92	-15.75	-16.71	-7.77
Comprensive Income & Other	19.28	56.87	49.57	60.78	24.92	-10.02
Total Common Equity	1,215	1,391	1,011	1,046	901.71	382.8
Minority Interest	609.29	653.28	352.13	341.7	-86.11	-10.51
Shareholders' Equity	1,824	2,044	1,363	1,388	815.59	372.3
Total Liabilities & Equity	3,332	3,387	2,546	2,234	1,447	889.41
Total Debt	989.23	842.5	656.02	417.24	55	24.13
Net Cash (Debt)	889.79	1,086	807.69	988.47	717.38	402.39
Net Cash Growth	-29.40%	34.43%	-18.29%	37.79%	78.28%	-27.38%
Net Cash Per Share	0.42	0.51	0.39	0.49	0.38	0.22
Filing Date Shares Outstanding	2,126	2,124	2,111	2,096	1,953	1,878
Total Common Shares Outstanding	2,126	2,123	2,111	2,096	1,953	1,878
Working Capital	1,681	1,858	1,219	1,226	665.26	329.54
Book Value Per Share	0.57	0.66	0.48	0.50	0.46	0.20
Tangible Book Value	1,197	1,371	984.18	1,005	861.57	342.08
Tangible Book Value Per Share	0.56	0.65	0.47	0.48	0.44	0.18
Land	-	350.49	265.52	188.58	175.82	129.43
Machinery	-	319.62	257.2	224.78	184.07	117.57
Construction In Progress	-	131.6	142.06	91.22	66.44	40.32
Order Backlog	-	-	-	-	94.7	49.4

Source: S&P Capital IQ. Standard template. Financial Sources.